Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × Keratosis × Clear all

Status

Sponsor Class

Study Type

Interventional 7 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 411 Neoplasms 289 Carcinoma, Non-Small-Cell Lung 245 Prostatic Neoplasms 192 Colorectal Neoplasms 180 Lung Neoplasms 152 Multiple Myeloma 110 Melanoma 96 Carcinoma, Renal Cell 96 Ovarian Neoplasms 85 Carcinoma, Hepatocellular 63 Neoplasm Metastasis 61 Pancreatic Neoplasms 59 Urinary Bladder Neoplasms 57 Leukemia, Lymphocytic, Chronic, B-Cell 57 Stomach Neoplasms 56 Colonic Neoplasms 47 Leukemia, Myeloid, Acute 46 Uterine Cervical Neoplasms 43 Recurrence 42 Lymphoma, Follicular 41 Liver Neoplasms 39 Lymphoma 35 Esophageal Neoplasms 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Lymphoma, Large B-Cell, Diffuse 31 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 31 Hematologic Neoplasms 31 Papillomavirus Infections 30 Kidney Neoplasms 29

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Graceway Pharmaceuticals, LLC

Keratosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡